Fundraising Fox
/Companies
Sign in

Ictero Medical

Houston, US · Founded 2018 · Delaware corporation · 4 known investors

Find your way into Ictero Medical

142 people in our graph share verified history with the Ictero Medical team — schools, employers, funds. One of them is your warm intro.

Elizabeth Hoffunlockedknows David Waters · together at Fannin Innovation Studio (overlapped)
×4knows the team · via Fannin Innovation Studio
×7knows the team · via The University of Texas at Austin

Ictero develops the CholeSafe System, a minimally invasive gallbladder ablation device for treating gallstone disease. The product targets patients seeking surgical outcomes without associated surgical risks.

BiotechHealthtechMedical Devices

Founders & leadership

Ictero Medical was founded in 2018 by Matthew Nojoomi, David Waters, and Kovi Bessoff.

MNMatthew Nojoomi
Matthew NojoomiCEO, Co-Founder
DWDavid Waters
David WatersCOO, Co-FounderDavid Waters is a physician and biomedical engineer who has spent 8+ years in medical device operations and investment diligence. As first employee and COO at Ictero Medical, he led capital strategy, clinical trial design and execution, and commercial strategy including market sizing and reimbursement pathway development for a catheter-based gallbladder ablation device.
KBKovi Bessoff
Kovi BessoffClinical Research Lead, Co-Founder
RKRaymond Kirk
Raymond KirkCMO

Board

AG
Ashok GowdaBoard directorPartner, MedTex Ventures; CEO, Biotex Inc. at MedTex Ventures LLC
JF
John FichthornBoard directorFounder and Managing Partner at MedTex Ventures LLC

Investors · 4

TMC Venture Fundlisted by TMC Venture FundHouston

How we know: TMC Venture Fund's portfolio page · Not right? Tell us

MedTex Ventures LLCreportedNorwalkvia Ashok Gowda · board

How we know: board seat on SEC Form D · funding news · Not right? Tell us

S3 VenturesreportedAustin · $500K – $15M

How we know: funding news · bizjournals.com · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$7.1M disclosed across 1 round · 2021

▶$7.1MraisedApr 2022 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew NojoomiExecutive Officer, Director
  • Dr. Raymond KirkExecutive Officer, Director
  • Ashok GowdaDirector
  • John FichthornDirector
  • David WatersExecutive Officer
Offering amount
$7.1M
Amount sold
$7.1M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

Companies working in the same space as Ictero Medical.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase II2023$966.6K
National Science FoundationPhase I2020$223.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Ictero Medical do?
Ictero develops the CholeSafe System, a minimally invasive gallbladder ablation device for treating gallstone disease. The product targets patients seeking surgical outcomes without associated surgical risks.
Who founded Ictero Medical?
Ictero Medical was founded by Matthew Nojoomi, David Waters, Kovi Bessoff in 2018.
Who are Ictero Medical's investors?
Ictero Medical's investors include Texas HALO Fund, TMC Venture Fund, MedTex Ventures LLC, S3 Ventures.
How much funding has Ictero Medical raised?
Ictero Medical has disclosed $7.1M raised across 1 round.
Where is Ictero Medical headquartered?
Ictero Medical is headquartered in Houston, US.